Rheumatology Research and Clinical Trials

Clinical studies and clinical trials are becoming one of the most important ways to advance the treatment of rheumatic diseases. Understanding how diseases affect the body has become essential to treating these diseases.

To test this promise, new and innovative clinical trials are undertaken to replace old therapies. Successful biotechnology approaches based on what is known about the cause and progression of disease has replaced the "trial and error" guesswork of the past. In this way, newer drugs can have a speedier path to the patient. New combinations of treatments will be employed based on clinical trial data.

In the future new biologic agents will deliver on the promise of improved efficacy, but they will meet the same standards for safety already in place for existing agents. The current experience with controlled clinical trials is of central importance in establishing the effectiveness of each therapy being studied.

Carefully selecting patients for clinical trials is critical for developing agents that have potential large costs and risks. Cedars-Sinai is poised to be a major institution to carry out these important clinical trials. The importance of prospective, randomized and controlled studies (sometimes requiring placebos) cannot be over-emphasized.

The patient population at Cedars-Sinai, as well as the cooperation of the 30 attending rheumatologists, is positioned to be on the forefront of innovative trials that will benefit our patients and bring new therapies to the practicing physician.

To search for information about specific clinical trials involving rheumatic diseases, click here.

Rheumatic Diseases Research Registry

Clinical research and studies are becoming one of the most important ways to advance the treatment of rheumatic diseases. Tests of promising new and innovative clinical studies help find cures, new and more effective therapies and provide information about the genetics of diseases.

As part of our commitment to the health of rheumatic diseases patients, the Division of Rheumatology at Cedars-Sinai has established the Rheumatic Diseases Research Registry. This is a database that contains health information provided by interested individuals who want to make a contribution to the future of medicine. As we begin clinical trials or studies at Cedars-Sinai, we contact appropriate candidates in the registry to see if they would like to participate.

If you have vasculitis, you may be eligible to enroll in our online Vasculitis Research Registry. This is a database that contains limited health information provided by individuals with vasculitis who are interested in hearing about current and future vasculitis research studies in which they may be eligible to participate, but without any obligation to participate.

If you are interested, please click on the link below.

Vasculitis Research Registry

The following clinical studies are underway:

If you would like more information about current research at Cedars-Sinai, please contact the Rheumatic Diseases Research Registry toll free at (888) 582-2226. Or, you can download the form* and mail or fax it to:

Rheumatic Diseases Research Registry
Cedars-Sinai Medical Center
8700 Beverly Blvd., Becker Suite 131
Los Angeles, CA 90048
Fax: (310) 423-6898 {Attn: Research Registry}